• 1
    Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495506.
  • 2
    Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993; 92: 141146.
  • 3
    Castelli WP, Garrison RJ, Wilson PW et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986; 256: 28352838.
  • 4
    Sharrett AR, Ballantyne CM, Coady SA et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104: 11081113.
  • 5
    Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213219.
  • 6
    Austin MA, Newman B, Selby JV et al. Genetics of LDL subclass phenotypes in women twins. Concordance, heritability, and commingling analysis. Arterioscler Thromb 1993; 13: 687695.
  • 7
    Campos H, Blijlevens E, McNamara JR et al. LDL particle size distribution. Results from the Framingham Offspring Study. Arterioscler Thromb 1992; 12: 14101419.
  • 8
    Krauss RM. Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu Rev Nutr 2001; 21: 283295.
  • 9
    Campos H, Willett WC, Peterson RM et al. Nutrient intake comparisons between Framingham and rural and Urban Puriscal, Costa Rica. Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size. Arterioscler Thromb 1991; 11: 10891099.
  • 10
    Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr 2006; 83: 102531; quiz 1205.
  • 11
    Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992; 12: 911919.
  • 12
    McLaughlin T, Reaven G, Abbasi F et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005; 96: 399404.
  • 13
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499502.
  • 14
    Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997; 20: 10871092.
  • 15
    Dreon DM, Fernstrom HA, Williams PT, Krauss RM. Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns. Am J Clin Nutr 2000; 71: 16111616.
  • 16
    Rainwater DL, Almasy L, Blangero J et al. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol 1999; 19: 777783.
  • 17
    Ginsberg HN, Zhang YL, Hernandez-Ono A. Metabolic syndrome: focus on dyslipidemia. Obesity (Silver Spring) 2006; 14 Suppl 1: 41S49S.
  • 18
    Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 22652272.
  • 19
    Siri PW, Krauss RM. Influence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr Atheroscler Rep 2005; 7: 455459.
  • 20
    Nordmann AJ, Nordmann A, Briel M et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 285293.
  • 21
    Stone NJ. Successful control of dyslipidemia in patients with metabolic syndrome: focus on lifestyle changes. Clin Cornerstone 2006; 8 Suppl 1: S15S20.
  • 22
    Purnell JQ, Kahn SE, Albers JJ et al. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab 2000; 85: 977982.
  • 23
    Després JP, Lemieux I, Bergeron J et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 10391049.
  • 24
    Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367377.
  • 25
    Williams PT. Weight set-point theory and the high-density lipoprotein concentrations of long-distance runners. Metab Clin Exp 1990; 39: 460467.
  • 26
    Williams PT. Weight set-point theory predicts HDL-cholesterol levels in previously obese long-distance runners. Int J Obes 1990; 14: 421427.
  • 27
    McLaughlin T, Carter S, Lamendola C et al. Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. Am J Clin Nutr 2006; 84: 813821.
  • 28
    Samaha FF, Foster GD, Makris AP. Low-carbohydrate diets, obesity, and metabolic risk factors for cardiovascular disease. Curr Atheroscler Rep 2007; 9: 441447.
  • 29
    Westman EC, Feinman RD, Mavropoulos JC et al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr 2007; 86: 276284.
  • 30
    Dreon DM, Fernstrom HA, Williams PT, Krauss RM. LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. Arterioscler Thromb Vasc Biol 1997; 17: 707714.
  • 31
    Enas EA, Mohan V, Deepa M et al. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr 2007; 2: 267275.
  • 32
    Hoang KC, Le TV, Wong ND. The metabolic syndrome in East Asians. J Cardiometab Syndr 2007; 2: 276282.